Cargando…
Prolonged life-threatening hypoglycaemia following dose escalation of octreotide LAR in a patient with malignant polysecreting pancreatic neuroendocrine tumour
This paper details the case of a 77-year-old male with refractory hypoglycaemia due to inoperable metastatic pancreatic neuroendocrine tumour (pNET) co-secreting insulin and gastrin. Multiple medical therapies were trialled with limited success, and we describe the complications experienced by our p...
Autores principales: | Abell, Sally K, Teng, Jessie, Dowling, Anthony, Hofman, Michael S, MacIsaac, Richard J, Sachithanandan, Nirupa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4313612/ https://www.ncbi.nlm.nih.gov/pubmed/25755880 http://dx.doi.org/10.1530/EDM-14-0097 |
Ejemplares similares
-
Accidental exposure to glimepiride from adulterated medication resulting in severe hypoglycaemia
por: Hayes, Annabelle G, et al.
Publicado: (2022) -
Advanced acromegaly: successful disease control for more than 16 years using octreotide LA
por: Elshafie, Omayma, et al.
Publicado: (2020) -
Exceptional diazoxide sensitivity in hyperinsulinaemic hypoglycaemia due to a novel HNF4A mutation
por: Arya, Ved Bhushan, et al.
Publicado: (2019) -
Successful neoadjuvant peptide receptor radionuclide therapy for an inoperable pancreatic neuroendocrine tumour
por: da Silva, Tiago Nunes, et al.
Publicado: (2018) -
Mitotane in the treatment of childhood adrenocortical carcinoma: a potent endocrine disruptor
por: Oddie, Philip D, et al.
Publicado: (2018)